Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial.
Jian-Wei LiWen-Jia ZuoDiana IvanovaXiao-Qing JiaLi LeiGuang-Yu LiuPublished in: Breast cancer research and treatment (2018)
Clinicaltrials.gov NCT01924078.